← Back to Clinical Trials
Recruiting NCT06705283

NCT06705283 Yoga and Vibration Training for Stress Urinary Incontinence in Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06705283
Status Recruiting
Phase
Sponsor Suleyman Demirel University
Condition Urinary Incontinence
Study Type INTERVENTIONAL
Enrollment 39 participants
Start Date 2024-11-01
Primary Completion 2025-11-30

Eligibility & Interventions

Sex Female only
Min Age 20 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
yoga and home exercisewhole body vibration training and home exercisehome exercise group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 39 participants in total. It began in 2024-11-01 with a primary completion date of 2025-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aimed to compare the effects of yoga and Whole Body Vibration Training on pelvic floor muscle strength, severity of urinary symptoms and UI-related quality of life in women with UI. The intervention period for the study was determined as 6 weeks. It has been decided that yoga practice will be done 3 times a week for 45 minutes, and whole body vibration training will be done for 45-55 minutes. The home exercise group will perform the planned exercise protocol every day for 6 weeks. The results of the study will be evaluated by statistical analysis as a result of the interventions and evaluations.

Eligibility Criteria

Inclusion Criteria: * Between the ages of 20-60, * patients with SUI or Mix UI with a predominant SUI component, * patients who have not received treatment with any physical therapy modality in the last 3 months, * patients who signed the informed consent form. Exclusion Criteria: * Those with neurological diseases that may cause incontinence * Those with prolapse * Those using intrauterine devices * Obesity (BMI \>30) * Patients with serious systemic diseases that prevent them from exercising (Cardiovascular disease, COPD, CVO and/or cancer) * Patients with pure urge or mixed UI with a predominant urge component * Patients with a history of thrombosis * Patients who engage in high-intensity sports activities for at least half an hour at least twice a week (tennis, aerobic exercise, running, exercises with body weight). * Patients with neurological or vestibular disease that may cause balance disorders * Patients with grade 3 or 4 knee and/or hip osteoarthritis * Patients with a history of knee and/or hip joint replacement surgery * Patients with kidney or gallbladder stones * Patients with acute disc herniation or spondylolisthesis

Contact & Investigator

Central Contact

Pinar Yasar, MSc

✉ pinarergoz@gmail.com

📞 +90 535 014 53 40

Principal Investigator

Zeliha Baskurt, Prof

STUDY DIRECTOR

Suleyman Demirel University

Frequently Asked Questions

Who can join the NCT06705283 clinical trial?

This trial is open to female participants only, aged 20 Years or older, up to 60 Years, studying Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06705283 currently recruiting?

Yes, NCT06705283 is actively recruiting participants. Contact the research team at pinarergoz@gmail.com for enrollment information.

Where is the NCT06705283 trial being conducted?

This trial is being conducted at Isparta, Turkey (Türkiye).

Who is sponsoring the NCT06705283 clinical trial?

NCT06705283 is sponsored by Suleyman Demirel University. The principal investigator is Zeliha Baskurt, Prof at Suleyman Demirel University. The trial plans to enroll 39 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology